Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen-Ting Chen

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Lancet. Respiratory Medicine|March 26, 2026
Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trialJavier A Neyra, Matthieu Legrand, Mark A Tidswell, et al.
Critical Care Medicine|July 4, 2020
Variation in Fluid and Vasopressor Use in Shock With and Without Physiologic Assessment: A Multicenter Observational StudyJen-Ting Chen, Russel Roberts, Melissa J Fazzari, et al.
Critical Care Medicine|July 25, 2020
Evaluation of Vasopressor Exposure and Mortality in Patients With Septic ShockRussel J Roberts, Todd A Miano, Drayton A Hammond, et al.
Chest|June 5, 2021
Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence StudyNida Qadir, Raquel R Bartz, Mary L Cooter, et al.
Critical Care Medicine|October 27, 2022
Wellness and Coping of Physicians Who Worked in ICUs During the Pandemic: A Multicenter Cross-Sectional North American SurveyKaren E A Burns, Marc Moss, Edmund Lorens, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19, , , et al.
JAMA|November 9, 2020
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical TrialWesley H Self, Matthew W Semler, Lindsay M Leither, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Lancet. Respiratory Medicine|March 26, 2026
Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trialJavier A Neyra, Matthieu Legrand, Mark A Tidswell, et al.
Critical Care Medicine|July 4, 2020
Variation in Fluid and Vasopressor Use in Shock With and Without Physiologic Assessment: A Multicenter Observational StudyJen-Ting Chen, Russel Roberts, Melissa J Fazzari, et al.
Critical Care Medicine|July 25, 2020
Evaluation of Vasopressor Exposure and Mortality in Patients With Septic ShockRussel J Roberts, Todd A Miano, Drayton A Hammond, et al.
Chest|June 5, 2021
Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence StudyNida Qadir, Raquel R Bartz, Mary L Cooter, et al.
Critical Care Medicine|October 27, 2022
Wellness and Coping of Physicians Who Worked in ICUs During the Pandemic: A Multicenter Cross-Sectional North American SurveyKaren E A Burns, Marc Moss, Edmund Lorens, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19, , , et al.
JAMA|November 9, 2020
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical TrialWesley H Self, Matthew W Semler, Lindsay M Leither, et al.
Pageof 3